DIA China 2022: ICH Day Live Stream

Dec. 8, 2022 | 8:30 – 9:30AM Beijing time

DIA China ICH Day 2022

Since its inception in 1990, founded by the drug regulatory agencies of the US, EU, and Japan along with industry associations, to its reform and establishment of the non-profit, non-governmental legal entity under Swiss law in 2015, International Council for Harmonzation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has successfully attracted regulators around the world to join and ensure greater coordination among the participating regulatory agencies. The purpose of ICH is to promote public health through international harmonization of technical requirements that contributes to the timely introduction of new medicines and continued availability of the approved medicines to patients, to the prevention of unnecessary duplication of clinical trials in humans, to the development, registration and manufacturing.

2022 is the 5th year since NMPA, China joined ICH Management Committee, to promote the ICH’s global development strategy, DIA China 2022 ICH Day will invite the speaker from ICH core member countries to forward look the ICH’s Further Initiatives from global perspectives, impact and updates for the new ICH Patient Focused Drug Development Guideline, as well ICH’s Key Achievements and Implementation in China.

ICH Q series, S series, E9R1, E6R3, E8R1 and M4QR2 will be also covered.

Review ICH Program

Review 2022 CAM PAG

Live Stream Content is Available to Members

Content is only one benefit of being a DIA member. Learn more and join today so you don't miss out! To access, sign in.

Join DIA

DIA China 2022: ICH Day Live Stream

Dec. 8, 2022 | 8:30 – 9:30AM Beijing time

Live Stream Content is Available to Members

获得信息并保持参与